Wealthfront Advisers
VRTX icon

Wealthfront Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$19.6M Sell
43,918
-3,014
-6% -$1.34M 0.05% 119
2025
Q1
$22.8M Buy
46,932
+5,913
+14% +$2.87M 0.06% 97
2024
Q4
$16.5M Buy
41,019
+1,819
+5% +$733K 0.05% 118
2024
Q3
$18.2M Sell
39,200
-490
-1% -$228K 0.06% 97
2024
Q2
$18.6M Sell
39,690
-707
-2% -$331K 0.06% 87
2024
Q1
$16.9M Sell
40,397
-263
-0.6% -$110K 0.06% 94
2023
Q4
$16.5M Sell
40,660
-605
-1% -$246K 0.06% 84
2023
Q3
$14.3M Sell
41,265
-356
-0.9% -$124K 0.06% 89
2023
Q2
$14.6M Buy
41,621
+1,742
+4% +$613K 0.06% 84
2023
Q1
$12.6M Buy
39,879
+4,883
+14% +$1.54M 0.06% 99
2022
Q4
$10.1M Sell
34,996
-3,525
-9% -$1.02M 0.05% 114
2022
Q3
$11.2M Buy
38,521
+4,596
+14% +$1.33M 0.06% 82
2022
Q2
$9.56M Buy
33,925
+18,566
+121% +$5.23M 0.05% 97
2022
Q1
$4.01M Buy
15,359
+8,236
+116% +$2.15M 0.02% 247
2021
Q4
$1.56M Buy
7,123
+1,425
+25% +$313K 0.01% 431
2021
Q3
$1.03M Buy
5,698
+26
+0.5% +$4.72K ﹤0.01% 465
2021
Q2
$1.14M Sell
5,672
-3,869
-41% -$780K 0.01% 414
2021
Q1
$2.05M Buy
9,541
+1,260
+15% +$271K 0.01% 260
2020
Q4
$1.96M Sell
8,281
-930
-10% -$220K 0.01% 234
2020
Q3
$2.51M Sell
9,211
-5
-0.1% -$1.36K 0.02% 144
2020
Q2
$2.68M Buy
9,216
+930
+11% +$270K 0.02% 123
2020
Q1
$1.97M Buy
8,286
+1,133
+16% +$270K 0.02% 146
2019
Q4
$1.57M Buy
7,153
+597
+9% +$131K 0.01% 232
2019
Q3
$1.11M Sell
6,556
-632
-9% -$107K 0.01% 270
2019
Q2
$1.32M Buy
7,188
+213
+3% +$39.1K 0.01% 222
2019
Q1
$1.28M Buy
6,975
+135
+2% +$24.8K 0.01% 214
2018
Q4
$1.13M Buy
+6,840
New +$1.13M 0.01% 215